Amgen Inc. Reports Data Security Incident to Texas AG

Amgen Inc. has officially reported a data security incident to the Texas Attorney General's office, with the filing dated August 18, 2026. The company indicated that this incident occurred on July 1, 2026, and is currently under investigation to determine its full scope and impact.

The specific nature of the breach and the categories of personal information involved were not detailed in the public filing. However, given Amgen's operations in the biotechnology and pharmaceutical sectors, the company manages extensive and sensitive information.

Amgen Inc. is recognized as a major independent biotechnology company, involved in the discovery, development, and delivery of human therapeutics. Its operations necessitate handling significant quantities of data, which could include various forms of personal information.

Individuals who receive official notification regarding this incident should carefully review the information provided by Amgen. It is generally advisable to monitor personal accounts for any unusual or unauthorized activity and to exercise caution with unsolicited communications that request personal details.

As the investigation by Amgen Inc. remains ongoing, further details may emerge. Staying informed through official company communications is important for those who believe their information may have been affected by this security event.